SEARCH RESULTS FOR: (*purchase New Brunswick driver*)(535114 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Asymmetric, Femoral/Tibia 65, Right Knee Spacer with gentamicin is a temporary implant whose main function is to preserve the articular space during a 2 Stage Revision Arthroplasty. Aids in the treatment of infection that emerged due to the implant of knee prosthesis. Once the patient has finished the specific treatment & no signs of the infection remain, the spacer is removed to be replaced by a definitive new prosthesis. This is a prolonged use implant (maximum intended use period of 180 days)
BIOCOMPOSITES LTD
885440
In Commercial Distribution
- 15060155712144 ()
- Asymmetric, Femoral/Tibia 65
885440
- Orthopaedic cement spacer
Asymmetric, Femoral/Tibia 58, Left Knee Spacer with gentamicin is a temporary implant whose main function is to preserve the articular space during a 2 Stage Revision Arthroplasty. Aids in the treatment of infection that emerged due to the implant of knee prosthesis. Once the patient has finished the specific treatment & no signs of the infection remain, the spacer is removed to be replaced by a definitive new prosthesis. This is a prolonged use implant (maximum intended use period of 180 days)
BIOCOMPOSITES LTD
885439
In Commercial Distribution
- 15060155712137 ()
- Asymmetric, Femoral/Tibia 58
885439
- Orthopaedic cement spacer
Asymmetric, Femoral/Tibia 58, Right Knee Spacer with gentamicin is a temporary implant whose main function is to preserve the articular space during a 2 Stage Revision Arthroplasty. Aids in the treatment of infection that emerged due to the implant of knee prosthesis. Once the patient has finished the specific treatment & no signs of the infection remain, the spacer is removed to be replaced by a definitive new prosthesis. This is a prolonged use implant (maximum intended use period of 180 days)
BIOCOMPOSITES LTD
885438
In Commercial Distribution
- 15060155712120 ()
- Asymmetric, Femoral/Tibia 58
885438
- Orthopaedic cement spacer
Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone.
BERKELEY ADVANCED BIOMATERIALS, LLC
C10 SWE12
In Commercial Distribution
- 00816125023776 ()
C10 SWE12
- Bone matrix implant, synthetic, non-antimicrobial
Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone.
BERKELEY ADVANCED BIOMATERIALS, LLC
C10 SWE10
In Commercial Distribution
- 00816125023769 ()
C10 SWE10
- Bone matrix implant, synthetic, non-antimicrobial
Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone.
BERKELEY ADVANCED BIOMATERIALS, LLC
C10 SWE08
In Commercial Distribution
- 00816125023752 ()
C10 SWE08
- Bone matrix implant, synthetic, non-antimicrobial
Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone.
BERKELEY ADVANCED BIOMATERIALS, LLC
C10 SWE06
In Commercial Distribution
- 00816125023745 ()
C10 SWE06
- Bone matrix implant, synthetic, non-antimicrobial
Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone.
BERKELEY ADVANCED BIOMATERIALS, LLC
C10 SWC08
In Commercial Distribution
- 00816125023738 ()
C10 SWC08
- Bone matrix implant, synthetic, non-antimicrobial
Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone.
BERKELEY ADVANCED BIOMATERIALS, LLC
C10 SWC07
In Commercial Distribution
- 00816125023721 ()
C10 SWC07
- Bone matrix implant, synthetic, non-antimicrobial
Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone.
BERKELEY ADVANCED BIOMATERIALS, LLC
C10 SWC06
In Commercial Distribution
- 00816125023714 ()
C10 SWC06
- Bone matrix implant, synthetic, non-antimicrobial